Who
Paul A. Keel
Director
Company insider
Files Form 4 as: Director, The Cooper Companies; Chief Executive Officer, Envista Holdings; Executive Vice President, 3m.
In numbers
- Trades disclosed
- 126
- Buys
- 2
- Sells
- 6
- Bought
- $1.0M
- Sold
- $9.8M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 3 Feb 2015
- Last trade
- 11 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 15 Sep 2026 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Bought | $250K4,701.015 at $53.18 | filing |
| 11 Sep 2026filed 15 Sep 2026 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Bought | $250K4,701.02 at $53.18 | filing |
| 18 Aug 2026filed 20 Aug 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —179,730 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | NVST Envista Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —159,900 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | NVST Envista Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —159,900 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —179,730 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | COO The Cooper Companiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,814 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | COO The Cooper Companiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,814 at $0.00 | filing |
| 25 May 2026filed 27 May 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code F | $300K12,811 at $23.43 | filing |
| 25 May 2026filed 27 May 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code F | $300K12,811 at $23.43 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code F | $350K11,840 at $29.59 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —48,670 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NVST Envista Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —132,885 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NVST Envista Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —132,885 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NVST Envista Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —115,320 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NVST Envista Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —115,320 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code F | $350K11,840 at $29.59 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —48,670 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | NVST Envista Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | $96K4,091 at $23.47 | filing |
| 1 Feb 2026filed 3 Feb 2026 | NVST Envista Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | $96K4,091 at $23.47 | filing |
News
Rosen Law Firm Continues Securities Probe Into Cooper CompaniesCOO · econotimes.com · 18 Oct 2026Cooper Companies (NASDAQ:COO) versus QuidelOrtho (NASDAQ:QDEL) Critical ContrastCOO · dailypolitical.com · 11 Oct 2026Cooper Companies Director Kurzius Buys 10,000 Shares for $539,100. What Does This Insider See in Shares?COO · fool.com · 7 Oct 2026
0 headlines in the last 90 days name Paul A. Keel; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.